Spectral characterization of degradation impurities of paroxetine hydrochloride hemihydrate

Scientia Pharmaceutica

Volumn 76, Issue 4, 2008, Pages 653-661

  Munigela, Nirmala ^a   Babu, J Moses ^a   Yerramilli, Anjaneyulu ^b   Kolla, Naveen Kumar ^a   Krishnamurthy, Vyas ^a   Mathad, Vijay Vittal ^a  

^a DR REDDY'S LABORATORIES LTD   (India)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

Degradation; HPLC; LC; MS; NMR; Paroxetine

Indexed keywords

3 [[(6 CHLORO 1,3 BENZODIOXOL 5 YL)OXY]METHYL] 5 (4 FLUOROPHENYL)PIPERIDINE; [ 4 (4 FLUOROPHENYL)PIPERIDIN 3 YL]METHANOL; HYDROCHLORIC ACID; HYDROGEN PEROXIDE; PAROXETINE; PAROXETINE HYDROCHLORIDE HEMIHYDRATE; PIPERIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG DEGRADATION; DRUG IMPURITY; DRUG ISOLATION; DRUG PURIFICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ANALYSIS;

EID: 58149265317     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.0808-08     Document Type: Article

References (5)

1. Dechant KL, Clissold SP. Paroxetine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depressive illness. Drugs. 1991; 41: 225-253. PMid: 1709852
2. Impurities in New Drug Products Q3A(R).2002. ICH Guidance for Industry: www.fda.gov/cber/gdlns/ichq3a.html
3. Berridge JC. Impurities in drug substances and drug products: new approaches to quantification and qualification. J Pharm Biomed Anal. 1995; 14: 7-12. doi:10.1016/0731-7085(95)01573-6
4. Alsante KM, Boutros P, Couturier MA, Friedmann RC, Harwood JW, Horan GJ, Jensen AJ, Liu Q, Lohr LL, Morris R, Raggon JW, Reid GL, Santafianos DP, Sharp TR, Tucker JL, Wilcox GE. Pharmaceutical impurity identification: A case study using a multidisciplinary approach. J Pharm Sci. 2004; 93: 2296-2309. doi:10.1002/jps.20120
5. Rourick RA, Volk KJ, Klohr SE, Spears T, Kerns EH, Lee MS. Predictive strategy for the rapid structure elucidation of drug degradants. J Pharm Biomed Anal. 1996; 14: 1743-1752. doi:10.1016/0731-7085(96)01843-2